NCT05847803 is a clinical trial of No intervention, questionnaire survey in Medical Informatics, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT05847803?

NCT05847803 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What drugs are being tested in NCT05847803?

Interventions in NCT05847803: No intervention, questionnaire survey.

What condition does NCT05847803 study?

NCT05847803 studies Medical Informatics, Intensive Care.

Is NCT05847803 still recruiting?

NCT05847803 is currently status unknown. Last updated 8 May 2023.

Last reviewed 2023-05-08 · How we verify

NCT05847803

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient Monitoring in the Intensive Care Unit

Status unknown Last updated 8 May 2023

What this trial tests

trial testing No intervention, questionnaire survey in Medical Informatics in 240 participants. Status unknown.

Timeline

5 February 2023

Primary endpoint
30 April 2023

15 May 2023

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	240
Start date	5 February 2023
Primary completion	30 April 2023
Estimated completion	15 May 2023
Sites	1 location across China

Drugs / interventions tested

No intervention, questionnaire survey

Conditions studied

Medical Informatics — all drugs for Medical Informatics →
Intensive Care — all drugs for Intensive Care →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

18 and older, any sex, with Medical Informatics or Intensive Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

a cross-sectional survey of nurses' perception of patient monitoring in the ICUs

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05847803 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 8 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05847803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing